Rodent studies show that using antibodies with different targets and modes of action in combination is more effective at preventing and treating COVID-19.
List view / Grid view
University of North Carolina at Chapel Hill
Filter the results
Collaborators have shown that the broad spectrum oral antiviral EIDD-2801 could be a potential prophylactic or therapeutic for COVID-19 and other coronaviruses.
Researchers have developed a novel peptide with a prolonged half-life that has demonstrated success in rhesus monkeys and mice for inhibiting HIV infections.
A study has revealed five new signalling processes in GPCR receptors on cells that have high therapeutic potential.